MARKET WIREYahoo • 18h ago
AstraZeneca (AZN) Q3 2026 Earnings Call TranscriptOncology and rare disease momentum offset cardiovascular headwinds.
Why AZN Stock surged +2.89% Today — RQD Quant Desk Flash
$174.40 +2.89% NYSE • Public Delayed / 60s Snapshot
AstraZeneca PLC (AZN) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
ROARABLE C • HOLD / WATCH
Cap $270.45B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERHOLD / WATCH • C
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw D+ · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+2.2% Base Target
WHALE OPTIONS TUG-OF-WAR:62% Call Buyers ($30.0M)
38% PutsMax Pain: $171.00
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why AZN Stock surged +2.89% Today — RQD Quant Desk Flash
AstraZeneca PLC (AZN) surged +2.89% to $174.40 as options desks priced 62% call premium vs. 38% put protection around the $171 max-pain magnet. Solid 41% profit margin (10% return on capital), mixed timing at 33x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 35% of its 52-week range ($153.41 – $212.71) with RSI-14 at 75.1 (OVERBOUGHT (>70)).
- ▸Whale Options Positioning: $30.0M in bullish call flow vs. $18.6M in put flow (Put/Call 0.62x, implied earnings swing ±6.6%).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 41% gross margin and $6.0B annual free cash flow.
Live AZN Headlines & Catalysts
MARKET WIRESeekingAlpha • 1d ago
AstraZeneca PLC (AZN) Q3 2026 Earnings Call TranscriptAstraZeneca PLC (AZN) Q3 2026 Earnings Call October 30, 2026 10:30 AM EDTCompany ParticipantsJoris Silon - Head of Investor RelationsPascal Soriot - CEO...
MARKET WIREYahoo • 1d ago
Q3 earnings round-up: AstraZeneca, AbbVie, KenvueMarket Domination Overtime Host Jared Blikre keeps track of several stocks moving in extended-hours trading after releasing earnings results, including AstraZeneca (AZN), AbbVie (ABBV), and Kenvue (KVUE).
MARKET WIREYahoo • 1d ago
AstraZeneca Gaps Up To Three-Month High As CEO Calls Out $20 Billion PotentialAstraZeneca stock gapped higher Friday as cancer drugs Enhertu and Tagrisso lent themselves to a solid third-quarter report.
CATALYSTYahoo • 1d ago
COVID Vaccine Giant AstraZeneca Stock Jumps 7%. What's Behind It?AstraZeneca Q3 earnings beat forecasts as the drugmaker launches a $1.5 billion savings plan to fund its AI-backed pipeline.
MARKET WIREYahoo • 1d ago
AstraZeneca Q3 Earnings Call HighlightsAstraZeneca (NYSE:AZN) reported continued revenue and earnings growth for the first nine months of 2026, supported by double-digit expansion in oncology, rare disease and respiratory and immunology, while loss-of-exclusi
CATALYSTYahoo • 1d ago
Learn Why The Bull Case For AstraZeneca Stock Could Change Following Earnings BeatAstraZeneca reported third quarter 2026 results ahead of expectations, with revenue of US$16.21b, net income of US$3.12b and core EPS of US$2.79, and reaffirmed full year guidance for mid to high single digit revenue gro
MARKET WIREYahoo • 1d ago
AstraZeneca cans late-stage Ultomiris trial on lacklustre efficacy predictionsUltomiris, one of AstraZeneca’s blockbuster sellers in Q3, is currently approved across five rare disease indications.
RISK WATCHYahoo • 1d ago
European Equities Traded in the US as American Depositary Receipts Fall in Friday TradingEuropean equities traded in the US as American depositary receipts were down 0.59% to 1,896.05 on th
CATALYSTYahoo • 1d ago
Drugs giant AstraZeneca reveals higher profits, savings planBritish pharmaceutical group AstraZeneca announced Friday a 23-percent jump in net profit for the third quarter and a new programme aiming for annual savings of $1.5 billion. The group added Friday that net profit reache
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live AZN Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
AZN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -0.38%▲ RESISTANCE BREAKOUT
2026-10-30O $183.6H $188.4L $183.1C $186.7VOL 5.46M
RES: $165.2SUP: $154.2SMA50: $164.5SMA200: $180.2
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
AZN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
25.3%/yr Implied 5Y Growth
vs. +22.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on AZN today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for AZN. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for AZN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
AZN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is AZN stock moving today?
Why AZN Stock surged +2.89% Today — RQD Quant Desk Flash. Solid 41% profit margin (10% return on capital), mixed timing at 33x P/E—hold if owned, no rush to chase.